drugset / Trial / NCT00512980
PVAG-14 Pilot for Intermediate Stages Hodgkin Lymphoma
RandomizedParallel-groupSingle-blindTreatment
Summary
A randomized phase II study of prednisone, vinblastine, doxorubicin, and gemcitabine in patients with intermediate stage Hodgkin's lymphoma
Timeline
- Start
- 2008-08
- Primary completion
- 2013-11
- Completion
- —
Outcome
Outcome not reported
Stopped (Enrollment): “lower recruitment rates as expected”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Doxorubicin | Other / unclassified | — | — |
| Comparator | Gemcitabine | Small molecule | — | — |
| Comparator | Prednisone | Other / unclassified | — | — |
| Comparator | Vinblastine | Small molecule | — | — |